Scarica l'app Stockscreener
2.64
3.65%
-0.10
Dopo l'orario di chiusura:
2.67
0.03
+1.14%
Precedente Chiudi:
$2.74
Aprire:
$2.74
Volume 24 ore:
486.18K
Relative Volume:
0.56
Capitalizzazione di mercato:
$238.31M
Reddito:
$70.14M
Utile/perdita netta:
$-76.24M
Rapporto P/E:
-2.3784
EPS:
-1.11
Flusso di cassa netto:
$-57.06M
1 W Prestazione:
-1.49%
1M Prestazione:
+6.02%
6M Prestazione:
+24.53%
1 anno Prestazione:
-25.00%
Intervallo 1D:
$2.59
$2.79
Intervallo di 1 settimana:
$2.455
$2.9299
Portata 52W:
$1.90
$6.08
Codexis Inc Stock (CDXS) Company Profile
Nome
Codexis Inc
Settore
Industria
Telefono
650-421-8100
Indirizzo
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Confronta CDXS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
2.64 | 227.47M | 70.14M | -76.24M | -57.06M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-19 | Downgrade | The Benchmark Company | Buy → Hold |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-05-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-29 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2023-11-07 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-08-07 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-05-09 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | Ripresa | Piper Sandler | Overweight |
| 2022-03-02 | Ripresa | Cowen | Outperform |
| 2021-04-12 | Iniziato | Piper Sandler | Overweight |
| 2021-03-01 | Iniziato | Stifel | Buy |
| 2021-02-26 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-10 | Iniziato | The Benchmark Company | Buy |
| 2019-01-17 | Aggiornamento | First Analysis Sec | Neutral → Outperform |
| 2018-05-16 | Iniziato | Stephens | Overweight |
| 2017-10-13 | Reiterato | H.C. Wainwright | Buy |
| 2017-05-31 | Iniziato | Jefferies | Buy |
| 2017-01-26 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| 2017-01-04 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2016-01-06 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Codexis Inc Borsa (CDXS) Ultime notizie
Is Codexis Inc. stock dividend yield sustainableMarket Activity Summary & Consistent Income Trade Recommendations - newser.com
Codexis (CDXS) chief technical officer Moore sells $15,629 in stock By Investing.com - Investing.com Nigeria
Codexis CFO Erbez sells $15,628 in shares By Investing.com - Investing.com Nigeria
Codexis CFO Erbez sells $15,628 in shares - Investing.com
Codexis (CDXS) chief technical officer Moore sells $15,629 in stock - Investing.com India
How Codexis Inc. stock benefits from strong dollarGold Moves & High Accuracy Investment Signals - newser.com
Will Codexis Inc. price bounce be sustainable2025 Market WrapUp & Stock Timing and Entry Methods - newser.com
How Codexis Inc. stock trades before earningsSell Signal & Safe Entry Trade Reports - newser.com
Technical signs of recovery in Codexis Inc.Trade Risk Assessment & Low Risk High Win Rate Picks - newser.com
Long term hold vs stop loss in Codexis Inc.Market Performance Summary & Consistent Growth Stock Picks - newser.com
Can you recover from losses in Codexis Inc.Gap Down & AI Powered Trade Plan Recommendations - newser.com
How hedge fund analytics apply to Codexis Inc. stockWeekly Trade Analysis & Scalable Portfolio Growth Ideas - newser.com
Codexis (CDXS) Reports Q4 Loss, Misses Revenue Estimates - MSN
Detecting price anomalies in Codexis Inc. with AIEarnings Recap Summary & Short-Term Swing Trade Alerts - newser.com
CDXSCodexis Reports First Quarter 2025 Financial Results - ADVFN
What institutional flow reveals about Codexis Inc.Weekly Trade Recap & Community Verified Trade Signals - newser.com
Will Codexis Inc. bounce back from current support2025 Major Catalysts & Long Hold Capital Preservation Plans - newser.com
Will Codexis Inc. continue its uptrend2025 Risk Factors & High Win Rate Trade Alerts - newser.com
Weiss Ratings Reiterates Sell (E+) Rating for Codexis (NASDAQ:CDXS) - MarketBeat
Is Codexis Inc a good long term investmentHead and Shoulders Patterns & Demo Trading Rooms Open Daily - earlytimes.in
Codexis Inc Stock Analysis and ForecastPortfolio Risk Assessment & Build a Dividend-Powered Portfolio - earlytimes.in
Biocatalysis And Biocatalyst Market Rewriting Long Term Growth Story| Codexis, Amano Enzyme, Biocatalysts - openPR.com
Codexis (NASDAQ:CDXS) Stock Price Passes Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Codexis Inc. stock retracement – recovery analysisJuly 2025 Pullbacks & Safe Capital Growth Stock Tips - newser.com
What does recent volatility data suggest for Codexis Inc.July 2025 Action & Daily Growth Stock Investment Tips - newser.com
Will Codexis Inc. stock recover after recent dropWeekly Trend Summary & Weekly Top Gainers Alerts - newser.com
News impact scoring models applied to Codexis Inc.Portfolio Growth Summary & Advanced Swing Trade Entry Alerts - newser.com
Codexis Inc Azioni (CDXS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Codexis Inc Azioni (CDXS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Erbez Georgia | Chief Financial Officer |
Oct 13 '25 |
Sale |
2.50 |
6,239 |
15,629 |
70,636 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):